Stay updated on Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.3 instead of v3.6.2, indicating a small update to the page's template or presentation. The update does not alter the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-03T22:09:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, reflecting a minor update to the page's template or data handling. This change does not signify a substantive update to the study content.
    Difference
    0.0%
    Check dated 2026-06-26T20:00:56.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a 'No longer looking for participants' status update indicating recruitment is closed. New help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') were added, the header 'Intervention / Treatment' was normalized to 'Intervention/Treatment', and the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:23:25.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a new software release applied to the site.
    Difference
    0.0%
    Check dated 2026-06-05T08:50:51.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 tag was added and the previous Revision: v3.5.3 tag was removed, indicating an updated revision of the page content. This is an administrative update with no direct user-facing changes.
    Difference
    0.0%
    Check dated 2026-05-14T23:12:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a newer revision of the page content.
    Difference
    0.0%
    Check dated 2026-04-30T16:57:22.000Z thumbnail image

Stay in the know with updates to Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.